Dave Grainger
banner
degrainger.bsky.social
Dave Grainger
@degrainger.bsky.social
Developmental biologist studying endothelial cell differentiation and heterogeneity

Postdoc in the Stone Lab - Institute of Developmental and Regenerative Medicine, Oxford, UK
Whew the most amazing I've ever seen the sea. Off the coast of Kerry, Ireland
September 10, 2025 at 9:41 PM
Giant fiancée took me out for my nearly-birthday
August 16, 2025 at 9:06 PM
Looking forward to the Spa GP this weekend. Ferrari sharing some cool artwork this week
July 23, 2025 at 3:32 PM
Great evening of talks at #pint25 in Oxford Tech Me Out theme. Very interesting talks from Alex and Jorge from @alpinef1.bsky.social followed by Muhammed Waqas from JLB.

Alpine even brought a front wing from their 2024 F1 car!
@pintofscience.uk
May 19, 2025 at 8:30 PM
Great weekend celebrating @emmarose64.bsky.social's graduation with friends and family. Very proud! 😊
May 18, 2025 at 6:35 PM
Some great images in this years @the-node.bsky.social image competition. Including my own "Thymus in the Spotlight" image taken in the @idrm.ox.ac.uk Zeiss CoE.

Vote for your favorite here: thenode.biologists.com/vote-for-you...
March 11, 2025 at 10:56 AM
Taking @emmarose64.bsky.social and my mum to their live first rugby games was great. Especially with it being such a good game and Gloucester winning 🍒⚪
January 26, 2025 at 8:34 PM
Finally, our proposed model showing LEC differentiation through in situ specification from ETV2+PROX1+ paraxial mesoderm-derived lymphangioblasts
January 13, 2025 at 2:31 PM
HCR (@hcrimaging.bsky.social) stainings suggest VEGFC/VEGFR3 signaling acts upstream of PROX1

In the absence of VEGFC/VEGFR3 signaling, specification of LECs from PXM stalls at the angioblast stage with Vegfc-/- embryos having more Etv2+Prox1- cells in the HDM.
January 13, 2025 at 2:31 PM
If migrating venous ECs are the major source of LECs, a substantial increase in EC numbers would be required to maintain venous integrity.

Analysis of cell cycle phase suggests angioblast-derived LECs and not venous ECs, are proliferative enough to support the rapid expansion of LECs.
January 13, 2025 at 2:31 PM
Conditional lineage tracing analyses using an inducible Pax3-CreERT2 line further highlighted the transient nature of this progenitor source, and demonstrated that lymphangioblasts give rise to LECs in various tissues.
January 13, 2025 at 2:31 PM
To better characterise lymphangioblast specification from PXM we performed snMultiome (RNA & ATAC) on Pax3-lineage progenitors and ECs at E9.5.

SCENIC+ analysis showed GRNs formed by known (ETV2/SOX18) and novel (EBF1/2) regulators of EC/LEC specification & differentiation in lymphangioblasts
January 13, 2025 at 2:31 PM
IF and HCR (@hcrimaging.bsky.social) staining of wholemount and vibratome sectioned E9.5 embryos identified lymphangioblasts as residing immediately dorsal to the cardinal vein in the Lbx1+ hypaxial dermomyotome in a pattern reminiscent of LECs migrating from the cardinal vein
January 13, 2025 at 2:31 PM
Surprisingly, we identified a population of cells that express both the angioblast marker Etv2 and the master regulator of LEC fate, Prox1. We have termed these cells lymphangioblasts.
January 13, 2025 at 2:31 PM
The prevailing model was that PXM-derived cells contribute to venous endothelium and then transdifferentiate to LECs

Irina Lupu's postdoc in Ollie's newly established lab aimed to define molecular features that may drive PXM's LEC competence using scRNA-seq on sorted EC and progenitor populations
January 13, 2025 at 2:31 PM
I'm not saying I spend too much time on the microscope but I can't help seeing blood vessels in christmas lights
December 3, 2024 at 9:26 PM